Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.
Dementia in multiple sclerosis: Report of a case with cortical gray matter involvement and frontotemporal-like clinical features.
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
One of the oldest patients with Neuromyelitis Optica in the literature.
The role of the immune system in the generation of neuropathic pain.
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations.
Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis.
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.
Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.
Myelin Basic Protein synthesis is regulated by small non-coding RNA 715.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data.
Complete bilateral horizontal internuclear ophthalmoplegia as a sign of multiple sclerosis relapse.
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Corrigendum.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.
Vitamin D - immunomodulatory actions and new potentialities.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
Molecular mimicry in the etiology of autoimmune diseases.
Teva targets $4 billion lupus market with laquinimod study
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis.

Pages